ZGN-1061

ZGN-1061 is an experimental drug that was developed by Zafgen for treatment of obesity and type 2 diabetes.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

ZGN-1061 is an experimental drug that was developed by Zafgen for treatment of obesity and type 2 diabetes. It has a similar mechanism of action as the discontinued drug Beloranib but was considered safer; however, its development was also halted because of safety concerns.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1367491505 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001367491505 · captured 2026-08-03 · ledger · version history

Cite this page as: encyclopegia.org, “ZGN-1061”, snapshot enwiki-001367491505. https://encyclopegia.org/a/zgn-1061

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.